Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6402-6413
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6402
Figure 1
Figure 1 Study flow chart. PEB: Post endoscopic retrograde cholangiopancreatography bacteremia; ERCP: Endoscopic retrograde cholangiopancreatography.
Figure 2
Figure 2 Bacterial type's dispersion among entire cohort and according to the days past endoscopic retrograde cholan-giopancreatography date. A: Bacterial type's dispersion among entire cohort; B: Bacterial type's according to the days past endoscopic retrograde cholangiopancreatography date. ERCP: Endoscopic retrograde cholangiopancreatography; ESBL: Extended spectrum beta-lactamase.
Figure 3
Figure 3 Appropriateness of antibiotic administration. A: Categorization of antibiotic prophylaxis appropriateness according to ASGE guidelines; B: Sub-categorization of prophylaxis appropriateness among cases who were actually administrated with antibiotics and those who were not.
Figure 4
Figure 4 Sub-categorization of prophylaxis administration in each category of prophylaxis appropriateness among cases with or without post endoscopic retrograde cholangiopancreatography bacteremia. ERCP: Endoscopic retrograde cholangiopancreatography.
Figure 5
Figure 5 Decision tree model for the outcome of post endoscopic retrograde cholangiopancreatography bacteremia. PEB: Post endoscopic retrograde cholangiopancreatography bacteremia. ERCP: Endoscopic retrograde cholangiopancreatography; EUS: Endoscopic ultrasound; FNA: Fine needle aspiration.
Figure 6
Figure 6 Receiver operating characteristic curves of the logistic regression model (broken line, AUC, 0. 766) and the decision tree model (continuous line, AUC, 0.778). ROC: Receiver operating characteristic.